RAP1ARAP1A, member of RAS oncogene family
Autism Reports / Total Reports
2 / 4Rare Variants / Common Variants
2 / 0Aliases
-Associated Syndromes
-Chromosome Band
1p13.2Associated Disorders
-Relevance to Autism
Whole genome and/or whole exome sequencing of 435 individuals in 116 ASD families in Viggiano et al., 2024 identified a de novo nonsense variant in the RAP1A gene in a male ASD proband who also presented with absent speech, moderate intellectual disability, and focal epilepsy. A rare damaging de novo missense variant in this gene had previously been reported in a male ASD proband from a multiplex family from the MSSNG cohort in Yuen et al., 2017. Woike et al., 2024 reported that the binding of RAP1A to the Shank/ProSAP N-terminal (SPN) domain of SHANK3 can differentially regulate its localization in dendrites.
Molecular Function
This gene encodes a member of the Ras family of small GTPases. The encoded protein undergoes a change in conformational state and activity, depending on whether it is bound to GTP or GDP. This protein is activated by several types of guanine nucleotide exchange factors (GEFs), and inactivated by two groups of GTPase-activating proteins (GAPs). The activation status of the encoded protein is therefore affected by the balance of intracellular levels of GEFs and GAPs. The encoded protein regulates signaling pathways that affect cell proliferation and adhesion, and may play a role in tumor malignancy. The protein encoded by the RAP1A gene also plays a role in nerve growth factor (NGF)-induced neurite outgrowth (Mochizuki et al., 2001).
External Links
SFARI Genomic Platforms
Reports related to RAP1A (4 Reports)
# | Type | Title | Author, Year | Autism Report | Associated Disorders |
---|---|---|---|---|---|
1 | Support | - | N Mochizuki et al. (2001) | No | - |
2 | Support | Whole genome sequencing resource identifies 18 new candidate genes for autism spectrum disorder | C Yuen RK et al. (2017) | Yes | - |
3 | Support | - | Woike D et al. (2023) | No | - |
4 | Primary | - | Marta Viggiano et al. (2024) | Yes | ID, epilepsy/seizures |
Rare Variants (2)
Status | Allele Change | Residue Change | Variant Type | Inheritance Pattern | Parental Transmission | Family Type | PubMed ID | Author, Year |
---|---|---|---|---|---|---|---|---|
c.73C>T | p.Gln25Ter | stop_gained | De novo | - | Simplex | 38519481 | Marta Viggiano et al. (2024) | |
c.427T>A | p.Phe143Ile | missense_variant | De novo | - | Multiplex | 28263302 | C Yuen RK et al. (2017) |
Common Variants
No common variants reported.
SFARI Gene score
Suggestive Evidence


Score Delta: Score remained at 3
criteria met
See SFARI Gene'scoring criteriaThe literature is replete with relatively small studies of candidate genes, using either common or rare variant approaches, which do not reach the criteria set out for categories 1 and 2. Genes that had two such lines of supporting evidence were placed in category 3, and those with one line of evidence were placed in category 4. Some additional lines of "accessory evidence" (indicated as "acc" in the score cards) could also boost a gene from category 4 to 3.
7/1/2024

Increased from to 3
Krishnan Probability Score
Score 0.48321199306334
Ranking 7718/25841 scored genes
[Show Scoring Methodology]
ExAC Score
Score 0.93418979781568
Ranking 2890/18225 scored genes
[Show Scoring Methodology]
Sanders TADA Score
Score 0.8027521281407
Ranking 2257/18665 scored genes
[Show Scoring Methodology]
Zhang D Score
Score -0.13678696831299
Ranking 13734/20870 scored genes
[Show Scoring Methodology]